Modulation of copper accumulation and copper-induced toxicity by antioxidants and copper chelators in cultured primary brain astrocytes

Journal of Trace Elements in Medicine and Biology

Volumn 32, Issue , 2015, Pages 168-176

  Bulcke, Felix ^a   Santofimia Castaño, Patricia ^b   Gonzalez Mateos, Antonio ^b   Dringen, Ralf ^a  

^a UNIVERSITY OF BREMEN   (Germany)

^b UNIVERSITY OF EXTREMADURA   (Spain)

Author keywords

Antioxidants; Astrocytes; Chelators; Copper; ROS; Toxicity

Indexed keywords

ASCORBIC ACID; BATHOCUPROINE DISULFONATE; COPPER CHLORIDE; EBSELEN; NEUROPROTECTIVE AGENT; PROPIDIUM IODIDE; TETRATHIOMOLYBDIC ACID; TROLOX C; UNCLASSIFIED DRUG; ANTIOXIDANT; CHELATING AGENT; COPPER; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL DAMAGE; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; COPPER METABOLISM; CYTOTOXICITY; DRUG EFFECT; INCUBATION TIME; LONG TERM EXPOSURE; MEMBRANE PERMEABILITY; NEUROPROTECTION; NEWBORN; NONHUMAN; PRIMARY CELL CULTURE; PRIORITY JOURNAL; RAT; REDUCTION KINETICS; ANIMAL; BRAIN; CELL CULTURE; CELL MEMBRANE; CELL SURVIVAL; CYTOLOGY; DRUG EFFECTS; METABOLISM; STAINING; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; ASTROCYTES; BRAIN; CELL MEMBRANE; CELL SURVIVAL; CELLS, CULTURED; CHELATING AGENTS; COPPER; RATS, WISTAR; REACTIVE OXYGEN SPECIES; STAINING AND LABELING;

EID: 84939623467     PISSN: 0946672X     EISSN: 18783252     Source Type: Journal    
DOI: 10.1016/j.jtemb.2015.07.001     Document Type: Article

References (82)

1. Scheiber I.F., Mercer J.F., Dringen R. Metabolism and functions of copper in brain. Prog. Neurobiol. 2014, 116:33-57.
2. Scheiber I.F., Dringen R. Astrocyte functions in the copper homeostasis of the brain. Neurochem. Int. 2013, 62:556-565.
3. Montes S., Rivera-Mancia S., Diaz-Ruiz A., Tristan-Lopez L., Rios C. Copper and copper proteins in Parkinson's disease. Oxid. Med. Cell. Longev. 2014, 2014:147251.
4. Choo X.Y., Alukaidey L., White A.R., Grubman A. Neuroinflammation and copper in Alzheimer's disease. Int. J. Alzheimers Dis. 2013, 2013:145345.
5. Telianidis J., Hung Y.H., Materia S., Fontaine S.L. Role of the P-type ATPases, ATP7A and ATP7B in brain copper homeostasis. Front. Aging Neurosci. 2013, 5:44.
6. Squitti R., Siotto M., Polimanti R. Low-copper diet as a preventive strategy for Alzheimer's disease. Neurobiol. Aging 2014, 35(Suppl. 2):S40-S50.
7. Bandmann O., Weiss K.H., Kaler S.G. Wilson's disease and other neurological copper disorders. Lancet Neurol. 2015, 14:103-113.
8. Dringen R., Scheiber I.F., Mercer J.F. Copper metabolism of astrocytes. Front. Aging Neurosci. 2013, 5:9.
9. Pal A., Prasad R. Recent discoveries on the functions of astrocytes in the copper homeostasis of the brain: a brief update. Neurotox. Res. 2014, 26:78-84.
10. Deitmer J.W., Rose C.R. Ion changes and signalling in perisynaptic glia. Brain Res. Rev. 2010, 63:113-129.
11. Hirrlinger J., Dringen R. The cytosolic redox state of astrocytes: maintenance, regulation and functional implications for metabolite trafficking. Brain Res. Rev. 2010, 63:177-188.
12. Brekke E., Morken T.S., Sonnewald U. Glucose metabolism and astrocyte-neuron interactions in the neonatal brain. Neurochem. Int. 2015, 82C:33-41.
13. Perea G., Sur M., Araque A. Neuron-glia networks: integral gear of brain function. Front. Cell Neurosci. 2014, 8:378.
14. Dringen R., Brandmann M., Hohnholt M.C., Blumrich E.M. Glutathione-dependent detoxification processes in astrocytes. Neurochem. Res. 2015, 10.1007/s11064-014-1481-1.
15. Fernandez-Fernandez S., Almeida A., Bolanos J.P. Antioxidant and bioenergetic coupling between neurons and astrocytes. Biochem. J. 2012, 443:3-11.
16. Scheiber I.F., Mercer J.F., Dringen R. Copper accumulation by cultured astrocytes. Neurochem. Int. 2010, 56:451-460.
17. Scheiber I.F., Dringen R. Copper-treatment increases the cellular GSH content and accelerates GSH export from cultured rat astrocytes. Neurosci. Lett. 2011, 498:42-46.
18. Scheiber I.F., Schmidt M.M., Dringen R. Copper export from cultured astrocytes. Neurochem. Int. 2012, 60:292-300.
19. Scheiber I.F., Schmidt M.M., Dringen R. Zinc prevents the copper-induced damage of cultured astrocytes. Neurochem. Int. 2010, 57:314-322.
20. Chen S.H., Lin J.K., Liu S.H., Liang Y.C., Lin-Shiau S.Y. Apoptosis of cultured astrocytes induced by the copper and neocuproine complex through oxidative stress and JNK activation. Toxicol. Sci. 2008, 102:138-149.
21. Qian Y., Zheng Y., Taylor R., Tiffany-Castiglioni E. Involvement of the molecular chaperone Hspa5 in copper homeostasis in astrocytes. Brain Res. 2012, 1447:9-19.
22. Bulcke F., Dringen R. Copper oxide nanoparticles stimulate glycolytic flux and increase the cellular contents of glutathione and metallothioneins in cultured astrocytes. Neurochem. Res. 2015, 40:15-26.
23. Bulcke F., Thiel K., Dringen R. Uptake and toxicity of copper oxide nanoparticles in cultured primary brain astrocytes. Nanotoxicology 2014, 8:775-785.
24. Lushchak V.I. Free radicals, reactive oxygen species, oxidative stress and its classification. Chem. Biol. Interact. 2014, 224C:164-175.
25. Poljsak B., Fink R. The protective role of antioxidants in the defence against ROS/RNS-mediated environmental pollution. Oxid. Med. Cell. Longev. 2014, 2014:671539.
26. Ahmad A., Syed F.A., Singh S., Hadi S.M. Prooxidant activity of resveratrol in the presence of copper ions: mutagenicity in plasmid DNA. Toxicol. Lett. 2005, 159:1-12.
27. Fukuhara K., Nagakawa M., Nakanishi I., Ohkubo K., Imai K., Urano S., Fukuzumi S., Ozawa T., Ikota N., Mochizuki M., Miyata N., Okuda H. Structural basis for DNA-cleaving activity of resveratrol in the presence of Cu(II). Bioorg. Med. Chem. 2006, 14:1437-1443.
28. Yamashita N., Murata M., Inoue S., Burkitt M.J., Milne L., Kawanishi S. α-tocopherol induces oxidative damage to DNA in the presence of copper(II) ions. Chem. Res. Toxicol. 1998, 11:855-862.
29. Marczewska J., Koziorowska J.H., Anuszewska E.L. Influence of ascorbic acid on cytotoxic activity of copper and iron ions in vitro. Acta Pol. Pharm. 2000, 57:415-418.
30. Li Y., Seacat A., Kuppusamy P., Zweier J.L., Yager J.D., Trush M.A. Copper redox-dependent activation of 2-tert-butyl(1,4)hydroquinone: formation of reactive oxygen species and induction of oxidative DNA damage in isolated DNA and cultured rat hepatocytes. Mutat. Res. 2002, 518:123-133.
31. Wei H., Frei B., Beckman J.S., Zhang W.J. Copper chelation by tetrathiomolybdate inhibits lipopolysaccharide-induced inflammatory responses in vivo. Am. J. Physiol. Heart Circ. Physiol. 2011, 301:H712-H720.
32. Wei H., Zhang W.J., McMillen T.S., Leboeuf R.C., Frei B. Copper chelation by tetrathiomolybdate inhibits vascular inflammation and atherosclerotic lesion development in apolipoprotein E-deficient mice. Atherosclerosis 2012, 223:306-313.
33. Ogra Y., Chikusa H., Suzuki K.T. Metabolic fate of the insoluble copper/tetrathiomolybdate complex formed in the liver of LEC rats with excess tetrathiomolybdate. J. Inorg. Biochem. 2000, 78:123-128.
34. Hamprecht B., Löffler F. Primary glial cultures as a model for studying hormone action. Methods Enzymol. 1985, 109:341-345.
35. Tulpule K., Hohnholt M.C., Hirrlinger J., Dringen R. Primary cultures of rat astrocytes and neurons as model systems to study metabolism and metabolite export from brain cells. Neuromethods 90: Brain Energy Metabolism 2014, 45-72. Springer, Heidelberg. J. Hirrlinger, H. Waagepetersen (Eds.).
36. Petters C., Dringen R. Comparison of primary and secondary rat astrocyte cultures regarding glucose and glutathione metabolism and the accumulation of iron oxide nanoparticles. Neurochem. Res. 2014, 39:46-58.
37. 67Cu by isolated human trophoblast cells. Biochim. Biophys. Acta 1992, 1135:123-128.
38. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
39. Hohnholt M.C., Blumrich E.M., Dringen R. Multiassay analysis of the toxic potential of hydrogen peroxide on cultured neurons. J. Neurosci. Res. 2015, 93:1127-1137.
40. Yeh C.J., Hsi B.L., Faulk W.P. Propidium iodide as a nuclear marker in immunofluorescence. II. Use with cellular identification and viability studies. J. Immunol. Methods 1981, 43:269-275.
41. Schneider C.A., Rasband W.S., Eliceiri K.W. NIH image to ImageJ: 25 years of image analysis. Nat. Methods 2012, 9:671-675.
42. Luther E.M., Koehler Y., Diendorf J., Epple M., Dringen R. Accumulation of silver nanoparticles by cultured primary brain astrocytes. Nanotechnology 2011, 22:375101.
43. Hohnholt M.C., Geppert M., Dringen R. Treatment with iron oxide nanoparticles induces ferritin synthesis but not oxidative stress in oligodendroglial cells. Acta Biomater. 2011, 7:3946-3954.
44. Zak B. Simple procedure for the single sample determination of serum copper and iron. Clin. Chim. Acta 1958, 3:328-334.
45. Gabryel B., Malecki A. Ebselen attenuates oxidative stress in ischemic astrocytes depleted of glutathione. Comparison with glutathione precursors. Pharmacol. Rep. 2006, 58:381-392.
46. Wang Z., Liu D., Wang J., Liu S., Gao M., Ling E.A., Hao A. Cytoprotective effects of melatonin on astroglial cells subjected to palmitic acid treatment in vitro. J. Pineal Res. 2012, 52:253-264.
47. Park E., Yu K.H., Kim do K., Kim S., Sapkota K., Kim S.J., Kim C.S., Chun H.S. Protective effects of N-acetylcysteine against monosodium glutamate-induced astrocytic cell death. Food Chem. Toxicol. 2014, 67:1-9.
48. Slamon N.D., Pentreath V.W. Antioxidant defense against antidepressants in C6 and 1321N1 cells. Chem. Biol. Interact. 2000, 127:181-199.
49. Kim E.J., Park Y.G., Baik E.J., Jung S.J., Won R., Nahm T.S., Lee B.H. Dehydroascorbic acid prevents oxidative cell death through a glutathione pathway in primary astrocytes. J. Neurosci. Res. 2005, 79:670-679.
50. Ferretti G., Bacchetti T., Moroni C., Vignini A., Curatola G. Copper-induced oxidative damage on astrocytes: protective effect exerted by human high density lipoproteins. Biochim. Biophys. Acta 2003, 1635:48-54.
51. Labbé S., Zhu Z., Thiele D.J. Copper-specific transcriptional repression of yeast genes encoding critical components in the copper transport pathway. J. Biol. Chem. 1997, 272:15951-15958.
52. McQuaid A., Mason J. A comparison of the effects of penicillamine, trientine, and trithiomolybdate on [35S]-labeled metallothionein in vitro; implications for Wilson's disease therapy. J. Inorg. Biochem. 1991, 41:87-92.
53. Scheiber I.F., Dringen R. Copper accelerates glycolytic flux in cultured astrocytes. Neurochem. Res. 2011, 36:894-903.
54. Kurisaki E., Kuroda Y., Sato M. Copper-binding protein in acute copper poisoning. Forensic Sci. Int. 1988, 38:3-11.
55. Garcia F., Ortega A., Domingo J.L., Corbella J. Accumulation of metals in autopsy tissues of subjects living in Tarragona County, Spain. J. Environ. Sci. Health A: Toxic Hazard. Subst. Environ. Eng. 2001, 36:1767-1786.
56. Letelier M.E., Lepe A.M., Faundez M., Salazar J., Marin R., Aracena P., Speisky H. Possible mechanisms underlying copper-induced damage in biological membranes leading to cellular toxicity. Chem. Biol. Interact. 2005, 151:71-82.
57. Vitale M., Zamai L., Mazzotti G., Cataldi A., Falcieri E. Differential kinetics of propidium iodide uptake in apoptotic and necrotic thymocytes. Histochemistry 1993, 100:223-229.
58. Dringen R., Pawlowski P.G., Hirrlinger J. Peroxide detoxification by brain cells. J. Neurosci. Res. 2005, 79:157-165.
59. Arnal N., Tacconi de Alaniz M.J., Marra C.A. Natural polyphenols may ameliorate damage induced by copper overload. Food Chem. Toxicol. 2012, 50:415-422.
60. Mattie M.D., Freedman J.H. Protective effects of aspirin and vitamin E (alpha-tocopherol) against copper- and cadmium-induced toxicity. Biochem. Biophys. Res. Commun. 2001, 285:921-925.
61. 1+ transporter of intestinal cells. Am. J. Physiol. Cell Physiol. 2003, 284:C1525-C1530.
62. Unsal C., Oran M., Albayrak Y., Aktas C., Erboga M., Topcu B., Uygur R., Tulubas F., Yanartas O., Ates O., Ozen O.A. Neuroprotective effect of ebselen against intracerebroventricular streptozotocin-induced neuronal apoptosis and oxidative stress in rats. Toxicol. Ind. Health 2013, 10.1177/0748233713509429.
63. 2+ concentration, stimulates glutamate release and increases GFAP content in rat hippocampal astrocytes. Toxicology 2008, 244:280-291.
64. Santofimia-Castano P., Salido G.M., Gonzalez A. Ebselen alters mitochondrial physiology and reduces viability of rat hippocampal astrocytes. DNA Cell Biol. 2013, 32:147-155.
65. Ozcelik D., Uzun H., Naziroglu M. N-acetylcysteine attenuates copper overload-induced oxidative injury in brain of rat. Biol. Trace Elem. Res. 2012, 147:292-298.
66. Zheng J., Lou J.R., Zhang X.X., Benbrook D.M., Hanigan M.H., Lind S.E., Ding W.Q. N-acetylcysteine interacts with copper to generate hydrogen peroxide and selectively induce cancer cell death. Cancer Lett. 2010, 298:186-194.
67. Santoso S.P., Chandra I.K., Soetaredjo F.E., Angkawijaya A.E., Ju Y.-H. Equilibrium studies of complexes between N-acetylcysteine and divalent metal ions in aqueous solutions. J. Chem. Eng. Data 2014, 59:1661-1666.
68. Limson J., Nyokong T., Daya S. The interaction of melatonin and its precursors with aluminium, cadmium, copper, iron, lead, and zinc: an adsorptive voltammetric study. J. Pineal Res. 1998, 24:15-21.
69. Mayo J.C., Tan D.X., Sainz R.M., Natarajan M., Lopez-Burillo S., Reiter R.J. Protection against oxidative protein damage induced by metal-catalyzed reaction or alkylperoxyl radicals: comparative effects of melatonin and other antioxidants. Biochim. Biophys. Acta 2003, 1620:139-150.
70. Parmar P., Limson J., Nyokong T., Daya S. Melatonin protects against copper-mediated free radical damage. J. Pineal Res. 2002, 32:237-242.
71. Romero A., Ramos E., de Los Rios C., Egea J., Del Pino J., Reiter R.J. A review of metal-catalyzed molecular damage: protection by melatonin. J. Pineal Res. 2014, 56:343-370.
72. Itoh S., Ozumi K., Kim H.W., Nakagawa O., McKinney R.D., Folz R.J., Zelko I.N., Ushio-Fukai M., Fukai T. Novel mechanism for regulation of extracellular SOD transcription and activity by copper: role of antioxidant-1. Free Radic. Biol. Med. 2009, 46:95-104.
73. Harrison F.E., May J.M. Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2. Free Radic. Biol. Med. 2009, 46:719-730.
74. Rice M.E. Ascorbate regulation and its neuroprotective role in the brain. Trends Neurosci. 2000, 23:209-216.
75. Rice M.E. Brain ascorbate: protective, yet permissive for redox signaling. Advances in Neurobiology 4: Neural Metabolism In Vivo 2012, 1051-1073. Springer, Heidelberg. I.-J. Choi, R. Gruetter (Eds.).
76. Lane D.J., Lawen A. The glutamate aspartate transporter (GLAST) mediates L-glutamate-stimulated ascorbate-release via swelling-activated anion channels in cultured neonatal rodent astrocytes. Cell Biochem. Biophys. 2013, 65:107-119.
77. Wilson J.X., Peters C.E., Sitar S.M., Daoust P., Gelb A.W. Glutamate stimulates ascorbate transport by astrocytes. Brain Res. 2000, 858:61-66.
78. Henry N.L., Dunn R., Merjaver S., Pan Q., Pienta K.J., Brewer G., Smith D.C. Phase II trial of copper depletion with tetrathiomolybdate as an antiangiogenesis strategy in patients with hormone-refractory prostate cancer. Oncology 2006, 71:168-175.
79. Redman B.G., Esper P., Pan Q., Dunn R.L., Hussain H.K., Chenevert T., Brewer G.J., Merajver S.D. Phase II trial of tetrathiomolybdate in patients with advanced kidney cancer. Clin. Cancer Res. 2003, 9:1666-1672.
80. Brewer G.J., Dick R.D., Grover D.K., LeClaire V., Tseng M., Wicha M., Pienta K., Redman B.G., Jahan T., Sondak V.K., Strawderman M., LeCarpentier G., Merajver S.D. Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: phase I study. Clin. Cancer Res. 2000, 6:1-10.
81. Kumar P., Yadav A., Patel S.N., Islam M., Pan Q., Merajver S.D., Teknos T.N. Tetrathiomolybdate inhibits head and neck cancer metastasis by decreasing tumor cell motility, invasiveness and by promoting tumor cell anoikis. Mol. Cancer 2010, 9:206.
82. Medici V., Sturniolo G.C. Tetrathiomolybdate, a copper chelator for the treatment of Wilson disease, pulmonary fibrosis and other indications. IDrugs 2008, 11:592-606.